@article{ecfeed9bce3943828f7c1a8cf67fa88a,
title = "Precision Medicine Clinical Trials A Conversation Between Peter O'Dwyer and Lale Kostakoglu",
author = "O'Dwyer, \{Peter J.\} and Lale Kostakoglu",
note = "Funding Information: Dr. O{\textquoteright}Dwyer: This cross-group study (Clinical and scientific impact of National Cancer Institute: Sponsored clinical trial network group treatment trials. Ann Oncol. 2021;32[suppl 5]:S1102–S1110) was initiated by SWOG investigators, and we need to give credit to the actual person who did the work, Joseph Unger, PhD, MS, from the Fred Hutchinson Cancer Research Center (Seattle, WA). The analysis systematically reviewed the survival impact of randomized phase 3 trials funded by NCI from 1980 through 2019. Over the past 40 years, adults in the United States diagnosed with cancer gained 14 million years of additional life thanks to the results of cancer clinical trials conducted by the NCTN. Furthermore, more than 80\% of the studies influenced care recommendations and formal guidelines. These results strikingly affirm the importance of doing this type of collective research that contributes significantly to the health care system. Dr. Unger{\textquoteright}s findings are all the more important in this time of increasing costs of clinical research. The return to the American people of government-funded investment in better cancer care has been remarkably solid—a huge impact.",
year = "2022",
month = jun,
day = "1",
doi = "10.2967/JNUMED.121.264320",
language = "English",
volume = "63",
pages = "808--811",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "6",
}